Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
432 results about "Tubercle" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
In anatomy, a tubercle is any round nodule, small eminence, or warty outgrowth found on external or internal organs of a plant or an animal.
Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
ActiveUS20050085486A1Increasing NO levelReduce expressionBiocidePharmaceutical delivery mechanismFemale Sexual Arousal DisorderCyclase
The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and / or heart. In certain embodiments, the compositions may comprise a PDE-4 inhibitor, a PDE-5 inhibitor, a compound that elevates cGMP and / or PKG, a stimulator of guanylyl cyclase and / or PKG, a combination of a compound that elevates cGMP, PKG or NO with an antioxidant that decreases ROS, or a compound that increases MMP activity.
Owner:LOS ANGELES BIOMEDICAL RES INST AT HARBOR UCLA MEDICAL CENT
Lung tubercle automatic detection method based on 3D convolutional neural network
ActiveCN106504232AReduce workloadSave time at workImage enhancementImage analysisNerve networkPhases of clinical research
The invention discloses a lung tubercle automatic detection method based on a 3D convolutional neural network(CNN). According to the invention, detection is creatively divided into two phases: (1) a candidate lung tubercle detection phase and (2) a false positive lung tubercle screening-out phase. In every phase, a unique 3D CNN is constructed and trained to be suitable for detection and screening-out of lung tubercles. The 3D CNN of the first phase is used to detect candidate lung tubercle positions of suspected lung tubercles preliminarily, and the 3D CNN of the second phase is used to screen out the false positive lung tubercles of the candidate tubercles, and finally, the positions of the tubercles in a whole lung CT image are found. The existence condition of the tubercles in the whole lung CT image is automatically detected, and by comparing with a conventional artificial tubercle detection way, the lung tubercle automatic detection method provided by the invention has advantages of high detection accuracy, strong robustness, high efficiency, short consumed time, and realizing convenient and effective detection of lung tubercles.
Owner:北京网医智捷科技有限公司
Remedy for sarcoidosis and method of treating the same
InactiveUS20070111956A1Formation was suppressedAntibacterial agentsBiocideGranulomatous diseaseActive component
The present invention provides a remedy for sarcoidosis, one of systemic granulomatous diseases, and a method for treating sarcoidosis. A remedy for sarcoidosis containing a Propionibacterium acnes-targeting antibiotic such as minocycline hydrochloride and clindamycin as an active component is prepared. Further, sarcoidosis is treated by administering this remedy for sarcoidosis to sarcoidosis patients.
Owner:JAPAN SCI & TECH CORP
Intrathecal and intratumoral superantigens to treat malignant disease
InactiveUS20060052295A1Improve effectivenessStrong specificityPeptide/protein ingredientsSnake antigen ingredientsDiseaseAbnormal tissue growth
The presence of tumor nodules in organs often results in serious clinical manifestations and the permeation by cancer cells of sheaths surrounding organs often produces clinical manifestations of pleural effusion, ascites or cerebral edema. The present invention addresses this problem by providing a method for treating tumors comprising (a) intratumoral administration of a superantigen and / or (b) intrathecal or intracavitary administration of a superantigen directly into the sheath. Intratumoral superantigen results in significant and sustained reduction of the tumor size. Intrathecal administration produces significant sustained reduction of the fluid accumulation associated with clinical improvement and prolonged survival. Useful superantigen compositions for intrathecal and intratumoral injection include tumoricidally effective homologues, fragments and fusion proteins of native superantigens. Also disclosed is combined therapy that includes intratumoral or intrathecal superantigen compositions in combination with (i) intratumoral low, non-toxic doses of one or more chemotherapeutic drugs or (ii) systemic chemotherapy at reduced and non-toxic doses of chemotherapeutic drugs.
Owner:JENQUEST
Tubercle bacillus target recognizing and counting algorithm based on diverse characteristics
InactiveCN101877074AFully automatedRealize intelligenceImage enhancementCharacter and pattern recognitionAcid-fastColor image
The invention relates to the field of medical image processing and mode recognition, in particular to a tubercle bacillus target recognizing and counting algorithm based on diverse characteristics. The algorithm comprises the following steps of: image preprocessing: carrying out image reinforcement and constructing median filter and Gaussian filter on a tubercle bacillus microimage; color image partition: carrying out fixed threshold partition based on HSV (Hue-Saturation-Value) color space on a preprocessed image and then carrying out adaptive threshold partition which is based on CIE L*a*b* color space and keeps a geometric shape of a target; communication block morphological analysis and target recognition: carrying out communication block analysis on the partitioned image; and tubercle bacillus target counting: estimating the quantity of tubercle bacillus targets in the image by utilizing a histogram statistics and multistrategy calculation method. The invention can effectively extract the bacillus targets in the tubercle bacillus microimage subjected to acid-fast stain from background and impurities and carry out accurate counting, thereby realizing the automation and the intellectualization of the detection of tubercle bacilli.
Owner:常州超媒体与感知技术研究所有限公司
Turbine and compressor employing tubercle leading edge rotor design
ActiveUS20090074578A1Improve the lift-to-drag ratioReduce resistancePropellersHydro energy generationLeading edgeEngineering
Owner:WHALE POWER CORP
Compounds and methods for treating tuberculosis infection
The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and / or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. The present invention is further directed to in vitro- and in vzivo-based methods of inhibiting Lpd and / or PDH activity. In certain embodiments, these methods are useful in inhibiting Lpd and / or PDH activity key to a pathogen's survival.
Owner:ACAD SINICA
System and method for intelligent recognizing and counting sputum smear micro-image tubercle bacillus
InactiveCN101221118AImprove efficiencyImprove accuracyImage analysisMaterial analysis by optical meansMicroscopic imageOphthalmology
The invention relates to a system and method for intelligently identify and count sputum smear microscopic image tubercle bacillus. The system includes a microscopic imaging device which is additionally provided with a CCD image sensor and the microscopic image of the tubercle bacillus is input into a computer by the CCD image sensor and an image collecting card; the lower side of the microscopic imaging device is provided with a 3D accurate control platform used for finishing the automatic switches of automatic focusing and continuous eyeshot so as to realize dynamic and automatic checking on the continuous eyeshot. A dry lens is adopted as an object lens and a multiple extender lens is added in a light path. Computer control realizes the dynamically intelligent identifying and counting on the tubercle bacillus with continuous eyeshot of the same sputum smear. The invention can replace manual spelling and counting, overcome the defects of manual spelling, improve the efficiency and accuracy of a sputum smear lens detecting method and is simultaneously helpful for improving the scientific level of a normal detecting method of the tubercle bacillus. The invention provides a scientific evidence for the clinical diagnosis and control of tuberculosis.
Owner:DONGHUA UNIV
Therapeutic applications of calcium electroporation to effectively induce tumor necrosis
ActiveUS9943599B2Limited amountImprove efficiencySonopheresisOrganic active ingredientsAbnormal tissue growthMedicine
The present inventors have shown that electroporation with calcium ions are efficient on cutaneous and subcutaneous nodules. In particular the present inventors here disclose that a solution comprising calcium ions (Ca2+) with a concentration of at least 0.1 M is extremely useful in a method of treating a neoplasm, such as cancer with means for causing transient permeabilization of the cell membranes of at least part of the neoplasm before, during and / or after administration of said solution, wherein said solution is administered with a ratio of 0.2 to 0.8 of the volume of said part of the neoplasm.
Owner:HERLEV HOSPITAL
Device and method for detecting sputum smear tubercle bacillus quickly
InactiveCN102304472AImprove detection efficiencyImprove the level ofBioreactor/fermenter combinationsBiological substance pretreatmentsGratingImage detection
The invention relates to a device and a method for detecting sputum smear tubercle bacillus quickly. The device comprises a support, a charge coupled device (CCD) image sensor, a microscopic imaging system, a computer system, a three-dimensional accurate control console, an X-axis motor, a Y-axis motor, a Z-axis motor, wherein a high-accuracy grating ruler with a grating sensor is arranged in the Z-axis direction of the support additionally; a light-emitting diode (LED) light source plate of which the light intensity is controllable is positioned on the lower side of the microscopic imaging system and is used as an object stage; and the computer system comprises three software functional modules, namely a control module, an image target fusion module and a neural network classification and counting module. The method comprises a visual sense area interpretation algorithm and an optimum detection path scanning algorithm which are used for image detection and a method for fusing targets twice in image segmentation. By the device and the method, the detection accuracy and efficiency of machine vision can be improved, and the scientific reference is provided for the clinical diagnosis and prevention and treatment of tuberculosis.
Owner:DONGHUA UNIV
Synthetic peptide, inhibitor to DNA viruses
The present invention relates to the identification of the active domain of Herpoxin, a DNA virus-inhibiting-protein which was isolated from cobra venom in U.S. Pat. No. 5,648,339 and has a molecular weight of 13.5 kDa We have isolated a fragment of Herpoxin which contains the active domain and which we have named Herp. Herp mimics the activity of Herpoxin in inhibiting the replication of DNA viruses. A synthetic version of the active fragment was produced having the amino acid sequence Asn-Leu-Tyr-Gln-Phe-Lys-Asn-Met-Ile-Gln. The synthetic version of Herp consisting of ten amino acids inhibits the replication of DNA viruses such as herpes viruses types 1 and 2, cytomegalovirus and varicella zoster virus as well as Tubercle bacilli.
Owner:LIPPS BINIE V +1
Method for screening compound with targeted action on inactive conformation of protein kinase
The invention belongs to the technical field of protein structure prediction and drug molecule virtual screening, specifically to a method for screening a compound with targeted action on an inactive conformation of a protein kinase. The method provided by the invention comprises a prediction method for the conformation of an active chain section of the protein kinase, wherein a corresponding DFG-out inactive conformation is generated from the DFG-in active conformation of the protein kinase; the method also comprises a selection method of a combined conformation after implementing butt joint of a II type inhibitor, and the selection method is used for selecting small molecules in conformation prediction and virtual screening. The method for screening a compound with targeted action on an inactive conformation of a protein kinase is already calculated and verified in the protein kinases of seven types of known inactive conformations, wherein the success rate is close to 96%. The method provided by the invention is already applied to the prediction of inactive conformation of PknB protein kinase of tubercle bacillus and the virtual screening of a possible II type inhibitor of PknB, and the bacteriostasis of two kinds of small molecules are already found according to bacteriostatic experiments.
Owner:FUDAN UNIV
Nucleic acid aptamer capable of being specifically bound to tubercle bacillus antigen and application thereof
Owner:武汉顺可达生物科技有限公司
Compound for inhibiting mycobacterium tuberculosis, screening method and uses thereof
InactiveCN102732474AInhibitory activityReduce workloadAntibacterial agentsOrganic active ingredientsDiseaseTyrosine
The present invention discloses a screening method of a compound for inhibiting mycobacterium tuberculosis. The method comprises the following steps: (1) establishing a screening model adopting tyrosine phosphatase as a target point: adopting genome DNA of tubercle bacillus H37 Rv as a template, adopting a PCR technology to clone tyrosine phosphatase gene, transforming host cells, culturing the transformant to obtain recombinant tyrosine phosphatase from the culture, carrying out enzyme activity analysis, and establishing the screening model adopting tyrosine phosphatase as the target point; and (2) adopting the screening model established in the step (1) to screen a compound providing inhibition activity for the tyrosine phosphatase. With the method of the present invention, the tyrosine phosphatase inhibitor with anti-mycobacterium tuberculosis effect can be rapidly and efficiently screened. In addition, the present invention further discloses a compound screened by using the screening method, and uses of the compound in preparations of drugs for treatments of diseases, wherein the inducement or one of the inducements of the diseases is the tyrosine phosphatase.
Owner:SUN YAT SEN UNIV
Traditional Chinese medicine composition for treating subacute thyroiditis and preparation method thereof
ActiveCN103099902AImprove clinical symptoms and signsLow recurrence rateAntiviralsUnknown materialsDrug withdrawalClinical study
The invention discloses a traditional Chinese medicine composition for treating subacute thyroiditis. The composition is a preparation prepared from the following raw materials by weight: 15-30 parts of hedyotis diffusa, 9-15 parts of honeysuckle, 15-30 parts of dandelion, 15-30 parts of Chinese violet, 9-15 parts of root of common peony, 9-15 parts of radix scrophulariae, 9-15 parts of peach kernel, 9-15 parts of baked turtle shell and 15-30 parts of sweet wormwood. According to clinical study on the treatment of subacute thyroiditis, the traditional Chinese medicine composition provided by the invention has total effective rate of 93.34%, which is significantly better than 73.33% of a prednisone group, and can effectively reduce erythrocyte sedimentation rate and CRP of subacute thyroiditis patients, and effectively improve clinical symptoms of the patients; although the cooling time, improvement time of neck pain and regression time of neck tenderness are longer than those of the prednisone group, the goiter or nodule disappearance time shows no obvious difference from those of the prednisone group; relapse rate after drug withdrawal is 3.33%, which is significantly lower than 20% of the prednisone group; and the composition has little adverse reaction, which is significantly lower than that of the prednisone group. The invention also discloses a preparation method of the traditional Chinese medicine composition granules.
Owner:LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE
Application of kelimycin in mycobacterium tuberculosis infection resistance
The invention relates to application of kelimycin in mycobacterium tuberculosis infection resistance. The application comprises the following main steps: clinical first-line antitubercular drugs isoniazide and rifamycin are used as contrast, and the antimycobacterial activity of kelimycin is detected by adopting an absolute concentration method. The result indicates that the activity of kelimycin on clinically separated mycobacterium tuberculosis including drug-resistance bacteria is remarkably superior to those of the clinical first-line contrast drugs isoniazide and rifamycin, and novel application of kelimycin is expected to be developed in treatment of tubercle bacillus infected diseases.
Owner:SHANGHAI TONGLIAN PHARMA CO LTD
Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use
InactiveCN1858059AHelp preventAids in healingAntibacterial agentsBacterial antigen ingredientsMolecular ImmunologyBCG vaccine
The present invention relates to molecular immunology technology, and aims at screening out antigen epitope molecular simulation peptide capable of exciting human body's protective immunoreaction against tubercle bacillus, researching protective immunoreaction mechanism against tuberculosis, and further developing new type of concatenate polyepitope tuberculosis vaccine. The present invention provides one kind of antigen epitope molecular simulation peptide capable of exciting human body's protective immunoreaction against tubercle bacillus, and the peptide contains the amino acid sequence selected from SEQ ID Nos. 2, 5, 10, 12, 14 and 15. The present invention also provides the screening process and use of the peptide. The present invention may be used in preventing and controlling tuberculosis.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
PCR (Polymerase Chain Reaction) specific primer, detecting kit and detecting method of benign and malignant thyroid nodule associated gene
ActiveCN108315424AStable structureMany detection sitesMicrobiological testing/measurementDNA preparationIntervention treatmentBiomarker (petroleum)
The invention discloses a PCR (Polymerase Chain Reaction) specific primer, a detecting kit and a detecting method of a benign and malignant thyroid nodule associated gene. Sequences of the PCR specific primer of the thyroid nodule benign and malignant associated gene are as shown in SEQ ID NO:1 to SEQ ID NO:54. The benign and malignant thyroid nodule associated gene disclosed by the invention is closely related to pathological indexes of cases of a benign thyroid nodule and a malignant thyroid nodule and can be used as a biomarker for carrying out benign and malignant thyroid nodule classification on a patient suffering from the thyroid nodules, and effective basis can be provided for clinical individual intervention treatment. The PCR specific primer, the detecting kit and the detecting method, disclosed by the invention, are capable of simultaneously detecting multiple benign and malignant thyroid nodule associated genes of multiple samples, and the detecting efficiency and the accuracy can be effectively increased; meanwhile, the cost is reduced, and the operating steps are simplified.
Owner:GUANGDONG GENERAL HOSPITAL +1
Reagent for detecting tubercle bacillus infection in vitro and method thereof
ActiveCN101446585AValid in vitro assayOvercome the disadvantages of unsatisfactory effectImmunoglobulins against bacteriaBiological testingBCG vaccineT cell
The invention discloses a reagent for detecting tubercle bacillus infection in vitro and a method thereof. The reagent comprises M233 polypeptide represented by SEQ ID No.1; and cytokine released from T cells is detected by contacting the M233 polypeptide or an analog thereof with the T cells of a tubercle bacillus host to determine whether the T cells identify the M233 polypeptide or the analog thereof. The reagent has the advantages of high sensitivity, good specificity, being free from interference of BCG vaccine and non-tuberculosis mycobacteria vaccine, being capable of detecting active pulmonary tuberculosis patients, the patients with dormant infection and healthy persons who contact with mycobacterium nontuberculosis. The reagent and the method are especially applicable to detecting tuberculosis and / or dormant infection thereof for Chinese people.
Owner:GUANGZHOU RHFAY BIOTECH CO LTD
Pharmaceutical composition for treating Hashimoto's thyroiditis and preparation method thereof
ActiveCN106421633ASymptoms improvedReduce volumePill deliveryGranular deliveryClinical studyInflammatory infiltration
The invention relates to a pharmaceutical composition for treating Hashimoto's thyroiditis and a preparation method thereof. The pharmaceutical composition is composed of bupleurum, radix curcumae, prunella vulgaris, rhizoma Dioscoreae Nipponicae, thunberg fritillary bulb, radix scrophulariae, edible tulip, astragalus, dark plum and other components, and can be made into granules, capsules, tablets or pills by the conventional pharmaceutical processes. The pharmaceutical composition has the effects of soothing liver-qi stagnation, reducing phlegm, removing stasis, and softening hardness to dissipate stagnation, and applies to patients with Hashimoto's thyroiditis and thyroid nodules. Clinical studies have shown that the pharmaceutical composition can significantly improve the symptoms of Hashimoto's thyroiditis, reduce the thyroid volume and isthmus thickness, and reduce the level of TgAb and TPOAb, and the total effective rate is 97.22%. In addition, for patients with thyroid nodules, nodules can be significantly reduced or even disappeare, no significant adverse reactions are presented in the course of treatment. Experimental studies have shown that the pharmaceutical composition reduces the level of TgAb and TPOAb, and reduces inflammatory infiltration and thyroid follicular damage.
Owner:BEIJING UNIV OF CHINESE MEDICINE
Quick identifying method and use for new low mycobacterium and tubercle mycobacterium
InactiveCN1715422ASolve the identification problemHigh sensitivityMicrobiological testing/measurementBacteroidesMicrobiology
The quick method of identifying bovine mycobacterium and tubercle mycobacterium includes: adding bovine mycobacterium Vallee strain genome DNA to proliferate one 294 bp segment, detecting target gene from bovine mycobacterium DNA with bovine mycobacterium primer, adding tubercle mycobacterium H37vR strain genome DNA to proliferate one 294 bp segment, proliferating target genome from tubercle mycobacterium DNA with tubercle mycobacterium primer, adopting the same upstream primer and different downstream primers and adopting two gene segments of 294 bp and annealing temperature of 67 deg c. The method of present invention is used in the direct detection of bacterial cultured matter and clinical sample.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Tubercle bacillus recombined protein and expressing purefying method and application thereof
The invention relates to anti-tubercule bacillus recombination protein. It belongs to gene recombination technique field. Its manufacturing includes the following steps: combining antigen the 190-198 polypeptides of the Ag85B-Mpt64 with Mtb8.4; cloning into escherichia coli vector to express; further purifying to gain. It is recorded as Ag85B-Mpt64190-198-Mtb8.4(SEQ.ID.NO.1). The protein can be used as anti tubercule bacillus subunit vaccine.
Owner:FUDAN UNIV
Minimally Invasive Method of Augmenting a Glans Penis with Intradermal Filler Material
InactiveUS20160354516A1Increase girthMaintaining sensationSurgical needlesMedical devicesFilling materialsInjection point
A method for augmenting the glans penis provides a minimally invasive introduction of injectable biocompatible material, including hyaluronic acid, to increase the girth of the glans penis while maintaining sensation in the penis. The method initially performs preoperative penile inspection of the girth of a penis. A biocompatible material is injected at a 12 o'clock, a 3 o'clock and 9 o'clock injection point relative to the glans penis. Where damage to the dorsal pedicle may occur, the injection points is at a 10'oclock and a 2 o'clock injection point. The biocompatible material is nontoxic and nonimmunogenic. The biocompatible can also be injected below the corona of the glans penis to create a mushroom effect causing nodules and pearls and intradermal injection causes blebs. Then, postoperative compressive dressing is applied to the penis. Then the penis is measured for postoperative changes in penile girth, and postoperative sexual satisfaction is recorded.
Owner:CHUANG GARY
Recombined streptomyces nodosus capable of producing amphotericin B and application thereof
ActiveCN107893048AHigh purityQuality improvementBacteriaTransferasesBiotechnologyS-Adenosyl-l-methionine
The invention discloses recombined streptomyces nodosus capable of producing amphotericin B and application thereof. The recombined streptomyces nodosus is obtained by introducing a kanamycin resistance gene sequence showed in SEQ ID NO.1 into streptomyces nodosus ZJB2016050; by introducing the kanamycin resistance gene, produced strains which have no resistance previously have kanamycin resistance, the purity and quality of the strains of seed culture mediums are improved, and strain contamination phenomena can be prevented from occurring during seed cultivation in a lab. By expressing a function gene, namely vitreoscilla hemoglobin (vhb), the yield of AmB is increased by 15%; by expressing a function gene, namely the S- adenosylmethionine synthetase gene (metk), the yield of AmB is increased by about 40%.
Owner:ZHEJIANG UNIV OF TECH
Mosaic vaccine of Ag85B and ESAT-6
The invention relates to Ag85B-ESAT-6 embedded protein vaccine, which is matched with agent MPL-TDM to immunize mouse, to make the IgG2a / IgG1 and IFN- gamma discharge higher then Ag85B-ESAT-6 fusion protein, while later one can generate same protective effect as BCG after infected by bacillus tubercle.
Owner:FUDAN UNIV
ELISA fleck diagnosis kit for tubercle bacillus infect and method for preparing specific antigen
The invention relates to a reagent kit for diagnosing enzyme linked immune spots infected by tubercle bacillus and a method for preparing a specific antigen. The reagent kit comprises a reagent kit body and a detection reagent arranged in the kit body; the detection reagent comprises a positive standard solution, a chromogenic agent, a concentrated detergent and a diluent; the detection reagent also comprises a specific antigen of mycobacterium tuberculosis, a coated INF-gamma resistant antibody and an enzyme label secondary antibody of a vector protein conjugate; the specific antigen of mycobacterium tuberculosis is fusion protein expressed by an ESAT-6 gene and an EIS gene of the mycobacterium tuberculosis; and the INF-gamma resistant antibody is a murine IgG antibody. The method for preparing the specific antigen comprises the following steps: proper tubercle bacillus special antigen ESAT-6 and EIS are combined; and the prepared recombining fusion protein contains main antigenic determinants of two antigens. The recombining fusion protein definitely contains a T cell epitope suitable for the limitation of different HLA, and does not influence results by different groups and different HLA distribution. Clinical tests on tuberculosis patients and healthy people of different groups show that the reagent kit has more excellent specificity and sensitivity than a current similar product.
Owner:THE THIRD PEOPLES HOSPITAL OF SHENZHEN
Fatty-liver-related liver cancer model building method based on knockout mice
ActiveCN105052830AIncrease incidenceMicrobiological testing/measurementAnimal husbandryKnockout animalGenotype
The invention relates to a fatty-liver-related liver cancer model building method based on knockout mice. The method is characterized in that APOE- / - and LDLR- / - knockout mice including female mice and male mice are selected, the female mice and the male mice are matched in number, and double knockout mice are obtained; a primer is designed, and the genotypes in mice are identified through a PCR (polymerase chain reaction) system; the PCR (polymerase chain reaction) system comprises an ApoE gene identification PCR conditions and LDLR gene identification PCR conditions; the double knockout mice are pregnant, and suckling mice are obtained; streptozotocin is injected to the suckling mice, the suckling mice begin a high-fat diet after ablactation, and finally the suckling mice surfer from liver cancer; it is identified that the suckling mice begin the high-fat diet after ablactation, fatty liver occurs six weeks later, NASH occurs 8-10 weeks later, dysplastic nodule occurs 13-16 weeks later, and the liver cancer occurs 18-24 weeks later. The occurrence rate of the liver cancer is about 100% 24 weeks later. The time when pure-gene APOE- / - and LDLR- / - knockout mice suffer from NASH and HCC due to the high-fat diet is advanced by 24-30 weeks, and the occurrence rate is high.
Owner:施军平
Composition based on tubercle bacillus antigenic polypeptide for diagnosing tuberculosis
Owner:INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA +1
Preparation method of rabies vaccine for human and its use
InactiveCN1824302AReduction in inflammatory nodulesLittle side effectsAntiviralsAntibody medical ingredientsRabiesAdjuvant
A human rabies vaccine is prepared from the existing rabies vaccine without adjuvant through adsorbing it by the aluminum hydroxide nanoparticles. Its adsorbed capacity is increased by 10-20 time. It can be used for emergency inoculation for preventing rabies as it has the fast release effect.
Owner:THE THIRD AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIV OF PLA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com